{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T12:32:18Z","timestamp":1756384338882},"reference-count":30,"publisher":"Spandidos Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.3892\/ol.2015.4040","type":"journal-article","created":{"date-parts":[[2015,12,21]],"date-time":"2015-12-21T03:22:31Z","timestamp":1450668151000},"page":"1469-1473","source":"Crossref","is-referenced-by-count":3,"title":["Coexistence of follicular lymphoma and an unclassifiable myeloproliferative neoplasm in a treatment-na\u00efve patient: A case report"],"prefix":"10.3892","volume":"11","author":[{"given":"GYEONGMIN","family":"JEONG","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JINHYONG","family":"KIM","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SEEUN","family":"HAN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JONGMIN","family":"LEE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KYUNGHYE","family":"PARK","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"CHUIYONG","family":"PAK","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JI-HUN","family":"LIM","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HEE JEONG","family":"CHA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HAWK","family":"KIM","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JAE-CHEOL","family":"JO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2015,12,21]]},"reference":[{"key":"key20180108095144_b1-ol-0-0-4040","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/ajh.23674","article-title":"Follicular lymphoma: 2014 update on diagnosis and management","volume":"89","author":"Freedman","year":"2014","journal-title":"Am J Hematol"},{"key":"key20180108095144_b2-ol-0-0-4040","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1182\/blood-2005-06-2508","article-title":"Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001","volume":"107","author":"Morton","year":"2006","journal-title":"Blood"},{"key":"key20180108095144_b3-ol-0-0-4040","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.ijrobp.2005.08.010","article-title":"Long-term outcome and mortality trends in early-stage, Grade 1-2 follicular lymphoma treated with radiation therapy","volume":"64","author":"Guadagnolo","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key20180108095144_b4-ol-0-0-4040","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1200\/JCO.2004.10.086","article-title":"Stage I and II follicular non-Hodgkin's lymphoma, long-term follow-up of no initial therapy","volume":"22","author":"Advani","year":"2004","journal-title":"J Clin Oncol"},{"key":"key20180108095144_b5-ol-0-0-4040","doi-asserted-by":"crossref","first-page":"3725","DOI":"10.1182\/blood-2005-01-0016","article-title":"Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP alone: Results of a prospective randomized study of the German Low-Grade Lymphoma Study Group","volume":"106","author":"Hiddemann","year":"2005","journal-title":"Blood"},{"key":"key20180108095144_b6-ol-0-0-4040","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1182\/blood-2004-08-3175","article-title":"CVP chemotherapy plus rituximab compared with CVP as first-line treatment for advanced follicular lymphoma","volume":"105","author":"Marcus","year":"2005","journal-title":"Blood"},{"key":"key20180108095144_b7-ol-0-0-4040","doi-asserted-by":"crossref","first-page":"4579","DOI":"10.1200\/JCO.2007.13.5376","article-title":"Phase III study of R-CVP compared with cyclophosphamide, vincristine, and prednisone alone in patients with previously untreated advanced follicular lymphoma","volume":"26","author":"Marcus","year":"2008","journal-title":"J Clin Oncol"},{"key":"key20180108095144_b8-ol-0-0-4040","first-page":"355","article-title":"Hematopathologic findings in the myeloproliferative disorders","volume":"22","author":"Dickstein","year":"1995","journal-title":"Semin Oncol"},{"key":"key20180108095144_b9-ol-0-0-4040","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/ajh.23895","article-title":"Polycythemia vera and essential thrombocythemia: 2015 update on diagnosis risk-stratification and management","volume":"90","author":"Tefferi","year":"2015","journal-title":"Am J Hematol"},{"key":"key20180108095144_b10-ol-0-0-4040","doi-asserted-by":"crossref","first-page":"671","DOI":"10.3109\/10428190109097666","article-title":"Molecular remission following high-dose hydroxyurea and fludarabine plus cytarabine in a patient with simultaneous acute myeloid leukemia and low-grade lymphoma","volume":"40","author":"Montefusco","year":"2001","journal-title":"Leuk Lymph"},{"key":"key20180108095144_b11-ol-0-0-4040","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1034\/j.1600-0609.2001.066004281.x","article-title":"Cytogenetic and immunophenotypic evidence of independent clonal origins of concomitant chronic lymphocytic leukaemia and acute myeloid leukaemia","volume":"66","author":"De Souza","year":"2001","journal-title":"Eur J Haematol"},{"key":"key20180108095144_b12-ol-0-0-4040","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1182\/blood-2003-12-4434","article-title":"Follicular lymphoma international prognostic index","volume":"104","author":"Solal-C\u00e9ligny","year":"2004","journal-title":"Blood"},{"key":"key20180108095144_b13-ol-0-0-4040","doi-asserted-by":"crossref","first-page":"3368","DOI":"10.1200\/JCO.2011.40.6546","article-title":"Effectiveness of first-line management strategies for stage I follicular lymphoma, Analysis of the National LymphoCare Study","volume":"30","author":"Friedberg","year":"2012","journal-title":"J Clin Oncol"},{"key":"key20180108095144_b14-ol-0-0-4040","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1080\/1042819021000016113","article-title":"Concomitant primary polycythemia vera and follicle center cell non-Hodgkin lymphoma, A case report and review of the literature","volume":"43","author":"Rizzi","year":"2002","journal-title":"Leuk Lymph"},{"key":"key20180108095144_b15-ol-0-0-4040","first-page":"365","article-title":"Spontaneous association of a chronic lympho- and myeloproliferative disease in the same patient. Histopathology","volume":"79","author":"Guzzini","year":"1988","journal-title":"Recenti Prog Med"},{"key":"key20180108095144_b16-ol-0-0-4040","first-page":"151","article-title":"T lymphoma of immature phenotype associated with polycythemia vera","volume":"51","author":"Kurchan","year":"1991","journal-title":"Medicina (B Aires)"},{"key":"key20180108095144_b17-ol-0-0-4040","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1365-2141.1994.tb03286.x","article-title":"Control of polycythaemia vera with photochemotherapy in a patient with cutaneous T-cell lymphoma","volume":"86","author":"Cottrill","year":"1994","journal-title":"Br J Haematol"},{"key":"key20180108095144_b18-ol-0-0-4040","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3322\/canjclin.31.1.57","article-title":"Twelve-year remission of polycythemia vera followingH odgkin's disease and chemotherapy","volume":"31","author":"Stolinsky","year":"1981","journal-title":"CA Cancer J Clin"},{"key":"key20180108095144_b19-ol-0-0-4040","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.0954-6820.1962.tb07186.x","article-title":"Complications and causes of death in polycythaemia vera","volume":"172","author":"Chievitz","year":"1962","journal-title":"Acta Medica Scand"},{"key":"key20180108095144_b20-ol-0-0-4040","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1182\/blood-2012-10-429134","article-title":"Platelet activation and inhibition in polycythemia vera and essential thrombocythemia","volume":"121","author":"Patrono","year":"2013","journal-title":"Blood"},{"key":"key20180108095144_b21-ol-0-0-4040","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1517\/14656566.2013.779671","article-title":"Polycythemia vera, Current pharmacotherapy and future directions","volume":"14","author":"Hensley","year":"2013","journal-title":"Expert Opin Pharmacother"},{"key":"key20180108095144_b22-ol-0-0-4040","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1586\/ehm.10.28","article-title":"JAK2 V617F and beyond: Role of genetics and aberrant signaling in the pathogenesis of myeloproliferative neoplasms","volume":"3","author":"Oh","year":"2010","journal-title":"Expert Rev Hematol"},{"key":"key20180108095144_b23-ol-0-0-4040","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s11864-014-0279-3","article-title":"Jak-2 positive myeloproliferative neoplasms","volume":"15","author":"Muxi","year":"2014","journal-title":"Curr Treat Options Oncol"},{"key":"key20180108095144_b24-ol-0-0-4040","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1182\/asheducation-2011.1.208","article-title":"Genetic and epigenetic complexity in myeloproliferative neoplasms","volume":"2011","author":"Cross","year":"2011","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"key20180108095144_b25-ol-0-0-4040","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1182\/blood-2005-03-1320","article-title":"Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders","volume":"106","author":"Jones","year":"2005","journal-title":"Blood"},{"key":"key20180108095144_b26-ol-0-0-4040","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1038\/sj.leu.2404373","article-title":"The JAK2 V617F mutation is rare in RARS but common in RARS-T","volume":"20","author":"Ceesay","year":"2006","journal-title":"Leukemia"},{"key":"key20180108095144_b27-ol-0-0-4040","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.1182\/blood-2005-05-1898","article-title":"The JAK2V617F activating mutation occurs in chronic myelomonocytic leukemia and acute myeloid leukemia, but not in acute lymphoblastic leukemia or chronic lymphocytic leukemia","volume":"106","author":"Levine","year":"2005","journal-title":"Blood"},{"key":"key20180108095144_b28-ol-0-0-4040","first-page":"2068","article-title":"[Follicular lymphoma complicated with myelofibrosis and macroglobulinemia at initial presentation]","volume":"54","author":"Kuroda","year":"2013","journal-title":"Rinsho ketsueki"},{"key":"key20180108095144_b29-ol-0-0-4040","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1158\/1055-9965.EPI-09-0353","article-title":"Increased risk of lymphoid neoplasms in patients with Philadelphia chromosome-negative myeloproliferative neoplasms","volume":"18","author":"Vannucchi","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"key20180108095144_b30-ol-0-0-4040","doi-asserted-by":"crossref","first-page":"454","DOI":"10.3324\/haematol.2010.033779","article-title":"Increased risk of lymphoid neoplasm in patients with myeloproliferative neoplasm, A study of 1,915 patients","volume":"96","author":"Rumi","year":"2011","journal-title":"Haematologica"}],"container-title":["Oncology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ol.2015.4040\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,2]],"date-time":"2019-09-02T15:41:18Z","timestamp":1567438878000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ol.2015.4040"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,21]]},"references-count":30,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2015,12,21]]},"published-print":{"date-parts":[[2016,2]]}},"alternative-id":["10.3892\/ol.2015.4040"],"URL":"https:\/\/doi.org\/10.3892\/ol.2015.4040","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,21]]}}}